Skip to main content

vaccine

CHICAGO/FRANKFURT • The chief scientist of Johnson & Johnson said the company expects to produce up to three billion doses of its Covid-19 jab next year, after the European Union (EU) approved the one-shot vaccine on Thursday.

The company is bringing on three manufacturing plants to produce the key drug substance for the vaccine. It will also have seven plants globally to handle the “fill and finish” – the final production steps and bottling into vials.

 

{iframe}https://www.straitstimes.com/world/united-states/jj-plans-to-produce-up-to-3-billion-doses-of-vaccine-next-year{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.